InvestorNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) to Present at H.C. Wainwright Global Investment Conference
Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharma company advancing cancer therapeutics, will participate in the H.C. Wainwright 27th Annual Global Investment Conference, scheduled for September 8–10, 2025, at the Lotte New York Palace Hotel in New York City. The company will host one-on-one meetings and deliver a presentation available virtually via kairospharma.com. To view the full press release, visit https://ibn.fm/s0U0R About Kairos Pharma Ltd. Based in…